A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Explore the Safety And Tolerability of Doses of E2007 up to a Maximum of 12 mg In Patients With Refractory Partial Seizures

Eisai Clinical Trials

Protocol # E2007-G000-208

Study Overview

Study Compound: E2007

Drug Name: perampanel

Registry #: NCT00416195, 2006-003702-26

Trial Period: Dec 2006 - Mar 2008

Indication: Epilepsy

Primary Endpoint:
1. Percentage of Responders During the Maintenance Phase [ Time Frame: Day 85 through Day 112]

Population
Males and females 18 Years to 70 Years (Adult, Older Adult)
Study Status
Completed
Study Phase
Phase 2
Countries
Belgium, Estonia, Finland, France, Latvia, Lithuania See moreSee less

Results

CSR Synopsis

Download PDF

Lay Summary

No download available

Publication reference citation

Maguire M. Response to “Perampanel and pregnancy: Could experience be a gloomy lantern that does not even illuminate its bearer?”. Epilepsy Behav. 2022 Apr;129:108654. doi: 10.1016/j.yebeh.2022.108654. Epub 2022 Mar 16. No abstract available.

Data Sharing

ClinicalStudyDataRequest.com (CSDR) is a multi sponsor site through which qualified researchers who wish to access clinical trial data and associated information in order to conduct further research can submit their research proposal or enquiry.

CSDR Sharing is available for this study.

CSDR	Availability
Clinical Trial Data

Redacted documents may be available upon request for this study.

Document type	Availability
Protocol
SAP
Sample CRF
Full CSR